[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355112-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355112-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","peritoneal-carcinomatosis-in-metastatic-non-small-cell-lung-cancer-review-of-the-literature","Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer - review of the literature","","Lung cancer ranks among the most frequent malignancies worldwide, and mortality remains extremely high. While metastasis commonly involves brain, bone, adrenal glands, and liver, modern therapies have been linked to a rise in atypical metastatic patterns, including peritoneal involvement in Non-Small Cell Lung Cancer. Adenocarcinoma most often drives peritoneal carcinomatosis, yet mechanisms remain unclear and diagnosis is frequently delayed. Clinical assessment may be limited until ascites appears, whereas imaging and peritoneal fluid cytology and molecular testing support evaluation. Management relies mainly on systemic treatment, with local approaches for symptom control, and future research is needed for prevention, earlier diagnosis, and optimized care.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/peritoneal-carcinomatosis-in-metastatic-non-small-cell-lung-cancer-review-of-the-literature/355112/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/peritoneal-carcinomatosis-in-metastatic-non-small-cell-lung-cancer-review-of-the-literature/355112.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"为什么非小细胞肺癌的腹膜癌病（peritoneal carcinomatosis）在临床上常被延迟发现？","Question",{"text":63,"@type":64},"症状往往缺乏特异性，容易被误认为系统性治疗背景下的晚期肺癌自然进展，导致诊断时机偏晚。腹水出现后临床评估才更具指向性。","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"有哪些检查方法用于腹膜癌病的诊断与评估？",{"text":68,"@type":64},"诊断可在腹水出现时以临床为主；同时，计算机断层扫描（CT）以及氟代脱氧葡萄糖正电子发射/CT（FDG PET/CT）有重要信息价值。通过引流获得的腹膜液还可进行细胞学与分子分析以辅助诊断。",{"name":70,"@type":61,"acceptedAnswer":71},"腹膜转移在非小细胞肺癌中的治疗策略主要依赖哪些手段？",{"text":72,"@type":64},"治疗主要依靠针对肺癌腹膜转移的全身治疗。局部区域干预通常保留用于症状控制，而预防、早期诊断与最佳管理仍需要进一步研究。","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355112,1790195242,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer and Metastasis Reviews (2026) 45:8 [https://doi.org/10.1007/s10555-026-10320-7](https://doi.org/10.1007/s10555-026-10320-7)  \nPeritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer: review of the literature  \nFausto Meriggi1 · Sara Cherri1 · Diego Gavezzoli2 · Tony Sabatini3 · Claudio Bna′4 · Alberto Zaniboni1  \nReceived: 20 August 2025 / Accepted: 14 February 2026 © The Author(s) 2026  \nAbstract  \nLung cancer has a remarkably high global incidence and ranks among the most frequent malignancies, with mortality rates placing it first worldwide. Although lung cancer typically metastasizes to the brain, bone, adrenal glands, and liver, the advent and efficacy of novel treatments such as immunotherapy and tyrosine kinase inhibitors have been associated with an increasing incidence of metastases in atypical sites, including peritoneal involvement in Non-Small Cell Lung Cancer. Adenocarcinoma is the histological subtype most frequently responsible for peritoneal carcinomatosis. Little is known about the underlying pathogenic mechanisms leading to peritoneal implantation, and diagnosis is often delayed until advanced disease stages, as symptoms are frequently nonspecific and may be mistaken for the natural progression of advanced lung cancer under systemic oncological treatment. Diagnosis is primarily clinical when ascites develops, but imaging modalities such as computed tomography and fluorodeoxyglucose positron emission tomography/computed tomography can be highly informative. Cytological and molecular analysis of peritoneal fluid obtained via drainage also contributes to diagnosis. Treatment mainly relies on systemic therapy for lung cancer with peritoneal metastases, while loco-regional interventions are generally reserved for symptom control. Considerable progress is still needed in the prevention, early diagnosis, and optimal management of peritoneal carcinomatosis, and future research, despite the rarity of cases, should focus on these aspects. In this review, we aim to analyze the limited literature currently available and explore future directions in the approach to peritoneal carcinomatosis in Non-Small Cell Lung Cancer.  \nKeywords Lung cancer · Peritoneal carcinomatosis · Molecular pathogenesis · Driver mutations  \n1 Introduction  \nLung cancer (LC) is among the most prevalent malignancies globally and represents the leading cause of cancer-related mortality. In the United States, the estimated numbers of new LC cases and related deaths in 2025 are 226,650 and 124,730, respectively [1] . Non-Small Cell Lung Cancer  \n* Fausto Meriggi  \n[fausto.meriggi@poliambulanza.it](fausto.meriggi@poliambulanza.it); [famerigg@libero.it](famerigg@libero.it)  \n1 Oncology Department, Istituto Ospedaliero Fondazione Poliambulanza, Via Leonida Bissolati 57, 25124 Brescia, Italy  \n2 Thoracic Surgery Department, Sacro Cuore Hospital Don Calabria, Negrar, VR, Italy  \n3 Internal Medicine Department, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy  \n4 Radiologic Department, Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy  \n(NSCLC) accounts for approximately 85% of all LC cases and is well known for its propensity to metastasize to the brain, bones, adrenal glands, and liver. Peritoneal carcinomatosis (PC) is an infrequent yet increasingly recognized site of metastasis in advanced NSCLC. PC represents a disseminated form of malignancy that typically arises from intra-abdominal primary tumors, such as ovarian, colorectal, and gastric cancers. Its occurrence in NSCLC, a malignancy primarily affecting the thoracic cavity, has historically been regarded as exceedingly rare. Nonetheless, recent advancements in imaging technologies, longer survival rates due to improved systemic treatments, and molecular profiling have contributed to an increased recognition of atypical metastatic patterns, including peritoneal spread, in NSCLC patients [2–4] . Clinical incidence of PC in NSCLC remains low, typically ranging","cbCain8DgnjhJFbM","https://ap.wps.com/l/cbCain8DgnjhJFbM","pdf",797427,"English","# Abstract\n# Introduction\n# Pathogenesis","[{\"question\":\"为什么非小细胞肺癌的腹膜癌病（peritoneal carcinomatosis）在临床上常被延迟发现？\",\"answer\":\"症状往往缺乏特异性，容易被误认为系统性治疗背景下的晚期肺癌自然进展，导致诊断时机偏晚。腹水出现后临床评估才更具指向性。\"},{\"question\":\"有哪些检查方法用于腹膜癌病的诊断与评估？\",\"answer\":\"诊断可在腹水出现时以临床为主；同时，计算机断层扫描（CT）以及氟代脱氧葡萄糖正电子发射/CT（FDG PET/CT）有重要信息价值。通过引流获得的腹膜液还可进行细胞学与分子分析以辅助诊断。\"},{\"question\":\"腹膜转移在非小细胞肺癌中的治疗策略主要依赖哪些手段？\",\"answer\":\"治疗主要依靠针对肺癌腹膜转移的全身治疗。局部区域干预通常保留用于症状控制，而预防、早期诊断与最佳管理仍需要进一步研究。\"}]","Peritoneal carcinomatosis in metastatic Non-Small Cell Lung Cancer - review of the literature | PDF",1790116077,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/167df16eee403234c512ef5dfc931776.webp",983,1305,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/608191af249a5c56a93d883653a852b5.webp",982,1304,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19ae0c94703c3486ad7d50a854e0b70f.webp",981,1303,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1253af7ad4df40496d6690714e7ae42a.webp",980,1301]